FDA Device Intelligence
HomeSmith & Nephew, Inc. › BIRMINGHAM HIP RESURFACING (BHR)

BIRMINGHAM HIP RESURFACING (BHR)

Smith & Nephew, Inc. · Model 74120152 · UDI-DI 03596010502575

NXT Prescription
0
510(k) clearances
6,885
Adverse events (18 deaths)
6
Recalls
9
Facilities

Description

ACETABULAR CUP HAP 52MM WITH IMPACTOR

Recalls

DateFirmReason
2021-07-14Smith & Nephew Orthopaedics Ltd. (Aurora)The nail head may become detached during surgery.
2018-05-11Smith & Nephew, Inc.The affected devices are manufactured to the same design specification as products intended for sale and use in the US but do not contain the FDA approved labeling (i.e., IFU and P
2018-05-11Smith & Nephew, Inc.The affected devices are manufactured to the same design specification as products intended for sale and use in the US but do not contain the FDA approved labeling (i.e., IFU and P
2015-06-03Smith & Nephew, Inc.The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks.
2015-06-03Smith & Nephew, Inc.The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks.
2015-06-03Smith & Nephew, Inc.The firm observed that the BIRMINGHAM HIP(TM) Resurfacing (BHR) System had revision rates which were higher than established benchmarks.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.